Novartis India Share Price in 2003: Chart, Monthly Trends, & Analysis

How did Novartis India shares perform in 2003?

Let's find out!

Novartis India share price in 2003 was ₹425.85 Its price on 1st January 2003 was ₹267.5, and by 31st December 2003 it moved to ₹425.85, giving a positive return of 59.19% for the year.

Novartis India Share Open, High, Low, and Close prices for the Year 2003 are as follows:

Open	High	Low	Close
₹267.5	₹463	₹212	₹425.85
1st Jan 2003	Occured in Dec 2003	Occured in Mar 2003	31st Dec 2003

This page will help you understand how Novartis India performed in 2003. Let's get started.

For complete insights into Novartis India’s incredible stock price performance and growth, see: Novartis India Historical Share Price Data from its IPO to 2025

Table: Novartis India Share Monthly Close, Low, High Prices for 2003

Month	Novartis India	Change%	↑High - ↓Low
Jan	₹259.95	-	↑ ₹284.95 ↓ ₹245
Feb	₹236	-9.3%	↑ ₹268.8 ↓ ₹235.05
Mar	₹217.2	-8%	↑ ₹244.7 ↓ ₹212
Apr	₹217.05	-0.1%	↑ ₹234 ↓ ₹216.05
May	₹228.15	5.1%	↑ ₹286 ↓ ₹212
Jun	₹235.75	3.3%	↑ ₹241 ↓ ₹225
Jul	₹258.55	9.6%	↑ ₹265 ↓ ₹231.1
Aug	₹256.45	-0.9%	↑ ₹263 ↓ ₹238
Sep	₹263.89	2.9%	↑ ₹297.5 ↓ ₹251.3
Oct	₹295.7	12%	↑ ₹368.5 ↓ ₹257.1
Nov	₹328.95	11.2%	↑ ₹369 ↓ ₹259
Dec	₹425.85	29.4%	↑ ₹463 ↓ ₹324.2

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Novartis India in 2003?

In 2003, the opening price of Novartis India share was ₹267.50. Today, the price stands at ₹672.25, reflecting a growth of 151.3%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2003 would have become ₹25,130.84 by 2025. This represents a CAGR of 4.28%.

---

You might also like to check: Novartis India Stock Price in 2002 or Novartis India Stock Price in 2004

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.